Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia

SIMPLE SUMMARY: In Asian breast cancer patients, whether the risks of major adverse cardio- and cerebrovascular events (MACCEs) are different between users of aromatase inhibitors (AIs) and selective estrogen receptor modulators (SERMs) remains uncertain. In this nationwide cohort study, the risks o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Wei-Ting, Chen, Po-Wei, Lin, Hui-Wen, Kuo, Yu-Hsuan, Lin, Sheng-Hsiang, Li, Yi-Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833815/
https://www.ncbi.nlm.nih.gov/pubmed/35158776
http://dx.doi.org/10.3390/cancers14030508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833815/
https://www.ncbi.nlm.nih.gov/pubmed/35158776
http://dx.doi.org/10.3390/cancers14030508

Ejemplares similares